Mecasermin Terminated Phase 2 Trials for Insulin-Like Growth Factor-1 Deficiency Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00572156rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency